Welcome

Welcome to the International Journal of Advances in Rheumatology, a CME-accredited quarterly review journal, in print and online, which systematically identifies and highlights the most important recent developments in the assessment and treatment of rheumatic diseases. The journal provides access to a critical and clinically relevant review of information regarding rheumatological medicine, including information pertaining to the diagnosis, treatment, and management of rheumatic diseases.

Each issue of the International Journal of Advances in Rheumatology features in-depth review articles, written by practicing rheumatologists and related disciplines, discussing current and emerging topics of clinical interest (our “Leading Articles”). These articles are commissioned according to relevant themes identified by the Editors-in-Chief, Editorial Advisory Board, and readers. We also present an ongoing, systematic review of key articles selected from the international literature (our “Clinical Reviews”, written by the Editors), expert comment and analysis of specific cases relating to rheumatic disease assessment and management (our “Case Studies”), and reports from the major international meetings.

Please feel free to browse this website. We hope you find the journal informative and interesting. We welcome your comments, letters, and ideas for leading articles, case studies, and meeting reports.

Volume 6 Issue 3

Download complete issue

| Download CME Activity

Leading Articles

IL-1-Targeted Therapy in Autoinflammatory Diseases

Hal M Hoffman, MD and Gary S Firestein, MD

The autoinflammatory diseases are a newly defined group of inflammatory disorders characterized by recurrent bouts of systemic inflammation. The elucidation of the molecular basis of these disorders has begun to shed light on the tightly regulated pathways involved in cytokine-mediated inflammation. This article examines the latest discoveries in this area, in particular advances in IL-1-targeted therapy and its implications for clinical management.

Standards of Care in Rheumatoid Arthritis

Theodora PM Vliet Vlieland, MD, PT, PhD

The development of clinical practice guidelines and recommendations, and sets of standards of care and quality indicators, are common strategies for improving the quality of healthcare. This article reviews the guidelines for the management of patients with rheumatoid arthritis (RA), and suggests that instituting quantative measurements of treatment quality could have a beneficial impact on clinical care.

Clinical Management of Fibromyalgia

Roland Staud, MD

Fibromyamlgia is a chronic condition characterized by widespread pain, tenderness, insomnia, and fatigue, with a high prevalence in those with rheumatic conditions such as systemic lupus erythematosus and Sjögren’s syndrome. This article reviews our current understanding the pathogenesis of the condition, and the pharmacological and non-pharmacological treatment strategies available.

Case Study

Long-Term Complications due to Ankylosing Spondylitis and Behçet’s Disease

Annemie JM Schuerwegh, MD, PhD, Machiel A Siezenga, MD, Leroy R Lard, MD, PhD, Tom WJ Huizinga, MD, PhD

This report documents the case of a 45-year-old Moroccan man with a 15-year history of seronegative HLA-B27-negative ankylosing spondylitis.

Clinical Reviews

Commentary and Analysis on Recent Key Papers

Other Remedica Publications

Click here for “Highlights” from recent EULAR and ACR meetings, and to obtain CME credit.

For detailed analyses of “Abstracts” from recent international meetings, click here.

Follow this link for a comprehensive analysis of recent advances in the treatment of rheumatic diseases, and to obtain CME credit.